Latest News - Bausch+Lomb

Wednesday, April 26, 2017 | FDA Approval/Clearance, Bausch+Lomb

Bausch + Lomb Receives 510(k) Clearance from FDA for Vitesse Vitrectomy System

Bausch + Lomb announced that it has received 510(k) clearance from the FDA for Vitesse, the first and only hypersonic, 100% open port vitrectomy system, according to a company news release. This new t…

Read the full story

Thursday, April 06, 2017 | FDA Approval/Clearance, Product Releases, Bausch+Lomb

Bausch + Lomb Receives FDA 510(k) Clearance for Stellaris Elite Phacoemulsification Platform

Bausch + Lomb announced that it has received 510(k) clearance from the FDA for the Stellaris Elite vision enhancement system, the company’s next generation phacoemulsification platform. The mach…

Read the full story

Thursday, March 30, 2017 | Management/Leadership, Bausch+Lomb, Valeant

Bausch + Lomb Announces US Management Team Leadership

Bausch + Lomb announced several changes to its management team designed to improve operational efficiencies. Joseph “Joe” Gordon, senior vice president and general manager, US Consumer …

Read the full story

Thursday, March 30, 2017 | Product Releases, Bausch+Lomb

Introducing Bausch + Lomb ULTRA for Astigmatism Contact Lenses

Bausch + Lomb announced the launch of Bausch + Lomb ULTRA for Astigmatism contact lenses, an innovative monthly silicone hydrogel lens that combines MoistureSeal technology, which helps to maintain 95…

Read the full story

Tuesday, March 21, 2017 | Glaucoma, Bausch+Lomb, Nicox

Bausch + Lomb and Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod

Bausch + Lomb and Nicox announced that the FDA has set a deadline of August 24, 2017 for its decision on the new drug application for latanoprostene bunod ophthalmic solution, 0.024%. Latanoprostene b…

Read the full story

Tuesday, March 07, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb UK/I Launches Digital Hub

Bausch + Lomb announced the launch of their enhanced digital hub Bausch.co.uk, a destination for patients and health care professionals to access the latest information on eye concerns and associated …

Read the full story

Thursday, March 02, 2017 | Conferences, Bausch+Lomb

Bausch + Lomb Educates Over 200 Eye Care Professionals During B+Lieve Symposium in San Francisco

Bausch + Lomb continued its educational and training initiative for eye care professionals with the year’s first B+Lieve symposium in San Francisco from February 27-28, 2017. During the event, m…

Read the full story

Wednesday, March 01, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Biotrue ONEday for Astigmatism Contact Lenses

Bausch + Lomb announced the introduction of Biotrue ONEday for Astigmatism daily disposable contact lenses. Approximately 73.2 million people in the U.S. are astigmatic, but only 8.8 million people ar…

Read the full story

Monday, February 27, 2017 | Glaucoma, Bausch+Lomb, Nicox

Bausch + Lomb And Nicox Resubmit FDA New Drug Application For Glaucoma Candidate Latanoprostene Bunod

Bausch + Lomb and Nicox announced the resubmission of a new drug application (NDA) to the FDA seeking approval for latanoprostene bunod ophthalmic solution, 0.024%. Latanoprostene bunod is an IOP-lowe…

Read the full story

Monday, February 13, 2017 | Earnings & Financials, Bausch+Lomb

Bausch + Lomb Ends Unilateral Pricing Policy

Bausch + Lomb became the latest contact lens company to move away from its Unilateral Pricing Policy (UPP) with the announcement late Friday that a “competitive imbalance” had forced the c…

Read the full story

Thursday, February 02, 2017 | Partnerships, Bausch+Lomb, Prevent Blindness

Bausch + Lomb and Prevent Blindness Urge Americans to Fight for Their Sight

Bausch + Lomb is partnering with Prevent Blindness for the second year in a row to urge patients to join the fight for their sight during age-related macular degeneration (AMD) awareness month. This y…

Read the full story

Thursday, January 26, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Specialty Vision Products Introduces ScleralFil Solution for Scleral Lens Insertion

Bausch + Lomb announced the launch of ScleralFil sterile buffered solution with no preservatives, which is indicated for inserting and rinsing scleral lenses. ScleraFil contains no preservative or mer…

Read the full story

Wednesday, January 18, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Zen RC Scleral Contact Lenses

Bausch + Lomb has introduced the Zen RC Scleral contact lens, offering eye care professionals (ECPs) a lens that is specifically designed to fit normal corneas and features SmartCurve technology, whic…

Read the full story

Tuesday, January 17, 2017 | Corporate Lawsuits, Bausch+Lomb

Bausch + Lomb Successfully Defends Patent Covering PreserVision Eye Vitamins in Case vs. Vitamin Health Inc.

Bausch + Lomb announced it has resolved its patent infringement lawsuit vs. Vitamin Health, filed in September 2013 in the U.S. District Court for the Western District of New York. Among other claims,…

Read the full story

Thursday, January 12, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb ULTRA for Presbyopia Contact Lenses Parameters Expanded

Bausch + Lomb announced that Bausch + Lomb ULTRA for Presbyopia contact lenses are now available in an expanded parameter range. Since the contact lenses first launched in February 2016, Bausch + Lomb…

Read the full story
Load More